Literature DB >> 11037861

Diabetes insipidus as a presenting symptom of acute myelogenous leukemia.

H A Frangoul1, D W Shaw, D Hawkins, J Park.   

Abstract

This report describes a case of diabetes insipidus associated with acute myelogenous leukemia. An 11-year-old boy presented with fatigue, polydipsia and polyuria. His evaluation revealed a diagnosis of acute myelogenous leukemia FAB-M2, and a water deprivation test confirmed the diagnosis of central diabetes insipidus. His brain magnetic resonance imaging (MRI) showed a thickened, enhancing pituitary stalk with absence of the normal hyperintense signal in the posterior pituitary. He was treated with systemic chemotherapy, intensive intrathecal therapy, and 1,000 cGy to the pituitary. The patient achieved a remission but continued to need desmopressin therapy to control his diabetes insipidus. Diabetes insipidus is a rare complication of acute myelogenous leukemia that can be caused by leukemic infiltration of the pituitary. The diabetes insipidus is irreversible despite intensive systemic and central nervous system chemotherapy and radiation.

Entities:  

Mesh:

Year:  2000        PMID: 11037861     DOI: 10.1097/00043426-200009000-00015

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis.

Authors:  Daniela Prayer; Nicole Grois; Helmut Prosch; Helmut Gadner; Anthony J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

2.  Concurrent Central Diabetes Insipidus and Acute Myeloid Leukemia.

Authors:  Stephanie L Pritzl; Daniel R Matson; Mark B Juckett; David J Ciske
Journal:  Case Rep Hematol       Date:  2021-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.